Sonova(US:SONVY)2022-11-14 13:48Financial Performance - Sonova Group sales reached CHF 1,846.6 million, a +17.9% increase in local currency (LC) and +15.1% in CHF [11] - Adjusted EBITA was CHF 398.1 million, a +3.0% increase in LC but a -2.0% decrease in CHF [11] - Adjusted EPS increased by +7.0% in LC to CHF 4.90 per share [11] - The gross profit margin (adj) was 69.6%, a decrease of -350bps in LC [54] Segment Results - Hearing Instruments (HI) segment sales were CHF 1,703 million, a +19.3% increase in LC [37] - HI business sales reached CHF 930 million, a +5.3% increase in LC [25] - Audiological Care (AC) business sales were CHF 640.1 million, a +17.3% increase in LC [25] - Consumer Hearing (CH) business sales were CHF 133 million [25] - Cochlear Implants (CI) segment sales reached CHF 143.5 million, a +3.0% increase in LC [25] Regional Performance - EMEA region sales reached CHF 879.8 million, a +14.9% increase in LC [32] - USA sales reached CHF 602.7 million, a +14.2% increase in LC [32] - Asia/Pacific sales reached CHF 224.0 million, a +47.1% increase in LC [32] Strategic Initiatives - More than CHF 60 million was invested in Audiological Care acquisitions, adding around 70 POS [17] - A new share buyback program was started in April, with approximately CHF 300 million bought back by September 30, 2022 [54, 77]